Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury

Michelle D. Rudman, James S. Choi, Ha Eun Lee, Sze Kiat Tan, Nagi Ayad, Jae Lee

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Inflammation is a major contributor to the secondary damage that occurs after spinal cord injury (SCI). The inflammatory response is coordinated by many different signaling modalities including the epigenetic modification of promoters and enhancers. Bromodomain and extraterminal domain-containing proteins (BETs; Brd2, Brd3, Brd4, BrdT) are epigenetic readers that bind acetylated histones to promote transcription of pro-inflammatory genes. BET inhibition is anti-inflammatory in animal models of cancer, rheumatoid arthritis, and coronary artery disease. However, the role of BETs in neuroinflammation remains largely unexplored. In this study, we investigated the role of BETs in promoting inflammation in neural cells and the ability of the BET inhibitor JQ1 to decrease inflammation acutely after SCI. Expression of BET mRNA was assessed via qPCR in purified primary mouse macrophages, astrocytes, neurons, oligodendrocytes, and microglia, as well as in naïve, sham-injured, and contusion-injured mouse spinal cord. Brd2, Brd3, and Brd4 mRNA were expressed in all purified primary neural cells and in the uninjured and injured mouse spinal cord. BET inhibition significantly attenuated proinflammatory signaling in all activated cell populations in vitro. To investigate the effects of BET modulation after SCI, the BET inhibitor JQ1 was injected intraperitoneally (30 mg/kg, bidaily) 3 h after spinal cord contusion in adult female C57BL/6 mice. By 3 days post-injury, BET inhibition significantly decreased pro-inflammatory cytokine expression and leukocyte recruitment to the injury site. However, this decrease did not lead to locomotor improvements or smaller lesion size. Taken together, our data implicate BETs as regulators of multiple key pro-inflammatory cytokines, and suggest that BETs can be pharmacologically inhibited to reduce inflammation acutely after SCI.

Original languageEnglish (US)
Pages (from-to)181-192
Number of pages12
JournalExperimental Neurology
Volume309
DOIs
StatePublished - Nov 1 2018

Fingerprint

Spinal Cord Injuries
Inflammation
Epigenomics
Spinal Cord
Cytokines
Messenger RNA
Contusions
Oligodendroglia
Wounds and Injuries
Microglia
Inbred C57BL Mouse
Astrocytes
Histones
Coronary Artery Disease
Rheumatoid Arthritis
Leukocytes
Anti-Inflammatory Agents
Animal Models
Macrophages
Protein Domains

Keywords

  • (+)-JQ1
  • Astrocytes
  • Epigenetic reader
  • Epigenetics
  • Macrophages
  • Microglia
  • Neurons
  • Neuroprotection
  • Neutrophils
  • Oligodendrocytes

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury. / Rudman, Michelle D.; Choi, James S.; Lee, Ha Eun; Tan, Sze Kiat; Ayad, Nagi; Lee, Jae.

In: Experimental Neurology, Vol. 309, 01.11.2018, p. 181-192.

Research output: Contribution to journalArticle

@article{6bdb30f68e174ed2b14b2b3f7d16a3a7,
title = "Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury",
abstract = "Inflammation is a major contributor to the secondary damage that occurs after spinal cord injury (SCI). The inflammatory response is coordinated by many different signaling modalities including the epigenetic modification of promoters and enhancers. Bromodomain and extraterminal domain-containing proteins (BETs; Brd2, Brd3, Brd4, BrdT) are epigenetic readers that bind acetylated histones to promote transcription of pro-inflammatory genes. BET inhibition is anti-inflammatory in animal models of cancer, rheumatoid arthritis, and coronary artery disease. However, the role of BETs in neuroinflammation remains largely unexplored. In this study, we investigated the role of BETs in promoting inflammation in neural cells and the ability of the BET inhibitor JQ1 to decrease inflammation acutely after SCI. Expression of BET mRNA was assessed via qPCR in purified primary mouse macrophages, astrocytes, neurons, oligodendrocytes, and microglia, as well as in na{\"i}ve, sham-injured, and contusion-injured mouse spinal cord. Brd2, Brd3, and Brd4 mRNA were expressed in all purified primary neural cells and in the uninjured and injured mouse spinal cord. BET inhibition significantly attenuated proinflammatory signaling in all activated cell populations in vitro. To investigate the effects of BET modulation after SCI, the BET inhibitor JQ1 was injected intraperitoneally (30 mg/kg, bidaily) 3 h after spinal cord contusion in adult female C57BL/6 mice. By 3 days post-injury, BET inhibition significantly decreased pro-inflammatory cytokine expression and leukocyte recruitment to the injury site. However, this decrease did not lead to locomotor improvements or smaller lesion size. Taken together, our data implicate BETs as regulators of multiple key pro-inflammatory cytokines, and suggest that BETs can be pharmacologically inhibited to reduce inflammation acutely after SCI.",
keywords = "(+)-JQ1, Astrocytes, Epigenetic reader, Epigenetics, Macrophages, Microglia, Neurons, Neuroprotection, Neutrophils, Oligodendrocytes",
author = "Rudman, {Michelle D.} and Choi, {James S.} and Lee, {Ha Eun} and Tan, {Sze Kiat} and Nagi Ayad and Jae Lee",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.expneurol.2018.08.005",
language = "English (US)",
volume = "309",
pages = "181--192",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury

AU - Rudman, Michelle D.

AU - Choi, James S.

AU - Lee, Ha Eun

AU - Tan, Sze Kiat

AU - Ayad, Nagi

AU - Lee, Jae

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Inflammation is a major contributor to the secondary damage that occurs after spinal cord injury (SCI). The inflammatory response is coordinated by many different signaling modalities including the epigenetic modification of promoters and enhancers. Bromodomain and extraterminal domain-containing proteins (BETs; Brd2, Brd3, Brd4, BrdT) are epigenetic readers that bind acetylated histones to promote transcription of pro-inflammatory genes. BET inhibition is anti-inflammatory in animal models of cancer, rheumatoid arthritis, and coronary artery disease. However, the role of BETs in neuroinflammation remains largely unexplored. In this study, we investigated the role of BETs in promoting inflammation in neural cells and the ability of the BET inhibitor JQ1 to decrease inflammation acutely after SCI. Expression of BET mRNA was assessed via qPCR in purified primary mouse macrophages, astrocytes, neurons, oligodendrocytes, and microglia, as well as in naïve, sham-injured, and contusion-injured mouse spinal cord. Brd2, Brd3, and Brd4 mRNA were expressed in all purified primary neural cells and in the uninjured and injured mouse spinal cord. BET inhibition significantly attenuated proinflammatory signaling in all activated cell populations in vitro. To investigate the effects of BET modulation after SCI, the BET inhibitor JQ1 was injected intraperitoneally (30 mg/kg, bidaily) 3 h after spinal cord contusion in adult female C57BL/6 mice. By 3 days post-injury, BET inhibition significantly decreased pro-inflammatory cytokine expression and leukocyte recruitment to the injury site. However, this decrease did not lead to locomotor improvements or smaller lesion size. Taken together, our data implicate BETs as regulators of multiple key pro-inflammatory cytokines, and suggest that BETs can be pharmacologically inhibited to reduce inflammation acutely after SCI.

AB - Inflammation is a major contributor to the secondary damage that occurs after spinal cord injury (SCI). The inflammatory response is coordinated by many different signaling modalities including the epigenetic modification of promoters and enhancers. Bromodomain and extraterminal domain-containing proteins (BETs; Brd2, Brd3, Brd4, BrdT) are epigenetic readers that bind acetylated histones to promote transcription of pro-inflammatory genes. BET inhibition is anti-inflammatory in animal models of cancer, rheumatoid arthritis, and coronary artery disease. However, the role of BETs in neuroinflammation remains largely unexplored. In this study, we investigated the role of BETs in promoting inflammation in neural cells and the ability of the BET inhibitor JQ1 to decrease inflammation acutely after SCI. Expression of BET mRNA was assessed via qPCR in purified primary mouse macrophages, astrocytes, neurons, oligodendrocytes, and microglia, as well as in naïve, sham-injured, and contusion-injured mouse spinal cord. Brd2, Brd3, and Brd4 mRNA were expressed in all purified primary neural cells and in the uninjured and injured mouse spinal cord. BET inhibition significantly attenuated proinflammatory signaling in all activated cell populations in vitro. To investigate the effects of BET modulation after SCI, the BET inhibitor JQ1 was injected intraperitoneally (30 mg/kg, bidaily) 3 h after spinal cord contusion in adult female C57BL/6 mice. By 3 days post-injury, BET inhibition significantly decreased pro-inflammatory cytokine expression and leukocyte recruitment to the injury site. However, this decrease did not lead to locomotor improvements or smaller lesion size. Taken together, our data implicate BETs as regulators of multiple key pro-inflammatory cytokines, and suggest that BETs can be pharmacologically inhibited to reduce inflammation acutely after SCI.

KW - (+)-JQ1

KW - Astrocytes

KW - Epigenetic reader

KW - Epigenetics

KW - Macrophages

KW - Microglia

KW - Neurons

KW - Neuroprotection

KW - Neutrophils

KW - Oligodendrocytes

UR - http://www.scopus.com/inward/record.url?scp=85052290688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052290688&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2018.08.005

DO - 10.1016/j.expneurol.2018.08.005

M3 - Article

C2 - 30134146

AN - SCOPUS:85052290688

VL - 309

SP - 181

EP - 192

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

ER -